Co-Diagnostics, Inc.
CODX
$0.40
-$0.06-12.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 223.86% | -66.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 223.86% | -66.31% | |||
| Cost of Revenue | 48.61% | -91.53% | |||
| Gross Profit | 355.75% | 127.15% | |||
| SG&A Expenses | -6.43% | -48.32% | |||
| Depreciation & Amortization | 3.92% | -21.48% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.43% | -28.65% | |||
| Operating Income | 5.78% | 28.18% | |||
| Income Before Tax | -2.61% | 31.87% | |||
| Income Tax Expenses | 2.50% | 246.34% | |||
| Earnings from Continuing Operations | -2.61% | 31.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.61% | 31.71% | |||
| EBIT | 5.78% | 28.18% | |||
| EBITDA | 6.11% | 28.38% | |||
| EPS Basic | 0.68% | 34.20% | |||
| Normalized Basic EPS | 8.65% | 30.51% | |||
| EPS Diluted | 2.71% | 33.11% | |||
| Normalized Diluted EPS | 8.65% | 30.51% | |||
| Average Basic Shares Outstanding | 3.31% | 3.80% | |||
| Average Diluted Shares Outstanding | 3.31% | 3.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||